Squamous cell carcinoma of the anal canal: Patterns and predictors of failure and implications for intensity-modulated radiation treatment planning

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 4, 2010, Pages 1064-1072

  Wright, Jean L ^a   Patil, Sujata M ^b   Temple, Larissa K F ^b   Minsky, Bruce D ^c   Saltz, Leonard B ^b   Goodman, Karyn A ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Anal carcinoma; Chemoradiation; Intensity modulated radiation treatment; Patterns of failure; Predictors of failure

Indexed keywords

ANAL CARCINOMA; CHEMORADIATION; INTENSITY-MODULATED RADIATION TREATMENT; PATTERNS OF FAILURE; PREDICTORS OF FAILURE;

CHEMOTHERAPY; HYDRAULIC STRUCTURES; PATIENT MONITORING; RADIATION; RADIOTHERAPY; TUMORS;

PHYSICAL THERAPY;

CISPLATIN; FLUOROURACIL; MITOMYCIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANAL CANAL; ANUS CARCINOMA; ARTICLE; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; TUMOR VOLUME; ANUS NEOPLASMS; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; COMPUTER ASSISTED RADIOTHERAPY; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PROCEDURES; TREATMENT FAILURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT FAILURE; TUMOR BURDEN;

EID: 77958030785     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.029     Document Type: Article

References (18)

1. M. Flam, M. John, and T.F. Pajak Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study J Clin Oncol 14 1996 2527 2539
2. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040 2049
3. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial J Am Med Assoc 299 2008 1914 1921
4. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research Lancet 348 1996 1049 1054
5. J.A. Martenson, S.R. Lipsitz, and H. Wagner Jr. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study Int J Radiat Oncol Biol Phys 35 1996 745 749
6. M. John, T. Pajak, and M. Flam Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08 Cancer J Sci Am 2 1996 205 211
7. P. Das, S. Bhatia, and C. Eng Predictors and patterns of recurrence after definitive chemoradiation for anal cancer Int J Radiat Oncol Biol Phys 68 2007 794 800
8. M.T. Milano, A.B. Jani, and K.J. Farrey Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome Int J Radiat Oncol Biol Phys 63 2005 354 361
9. C. Menkarios, D. Azria, and B. Laliberte Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: A comparison of conventional and IMRT plans Radiat Oncol 2 2007 41 52
10. Y.J. Chen, A. Liu, and P.T. Tsai Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes Int J Radiat Oncol Biol Phys 63 2005 274 281
11. J.K. Salama, L.K. Mell, and D.A. Schomas Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience J Clin Oncol 25 2007 4581 4586
12. A. Eisbruch, L.H. Marsh, and L.A. Dawson Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing Int J Radiat Oncol Biol Phys 59 2004 28 42
13. D.M. Cannon, and N.Y. Lee Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 70 2008 660 665
14. N.D. Nigro, H.G. Seydel, and B. Considine Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal Cancer 51 1983 1826 1829
15. R.J. Myerson, M.C. Garofalo, and I.E. Naqa Elective clinical target volumes for conformal therapy in anorectal cancer: A Radiation Therapy Oncology Group Consensus Panel contouring atlas Int J Radiat Oncol Biol Phys 74 2008 824 830
16. R. Roohipour, S. Patil, and K.A. Goodman Squamous-cell carcinoma of the anal canal: Predictors of treatment outcome Dis Colon Rectum 51 2008 147 153
17. N.J. Meropol, D. Niedzwiecki, and B. Shank Induction therapy for poor-prognosis anal canal carcinoma: A phase II study of the Cancer and Leukemia Group B (CALGB 9281) J Clin Oncol 26 2008 3229 3234
18. S. Roels, W. Duthoy, and K. Haustermans Definition and delineation of the clinical target volume for rectal cancer Int J Radiat Oncol Biol Phys 65 2006 1129 1142